Side-by-side comparison of AI visibility scores, market position, and capabilities
Casana's Heart Seat received FDA 510(k) clearance for heart rate and SpO2 monitoring; raised $44M total; awaiting additional clearance for cuffless blood pressure before commercial launch.
Casana is a Rochester, New York-based medical device company developing the Heart Seat, a smart toilet seat designed to passively monitor cardiovascular health indicators for patients managing heart failure, hypertension, and other cardiac conditions at home. The device replaces a standard toilet seat and captures heart rate, blood oxygen saturation (SpO2), and is being developed to also monitor cuffless blood pressure — all without requiring the patient to take any conscious action. This passive monitoring model addresses a critical compliance gap in remote patient monitoring, where traditional wearables and cuffs require patient participation that many elderly or chronically ill patients cannot sustain.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.